LYEL
Lyell Immunopharma, Inc. Common Stock
$19.29
0.00%
0.00
Notify me if price changes either direction
Buy LYEL stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
449.6M
Enterprise value
262.2M
Trailing PE
-1.2029887730277
Forward PE
-23.315475
PEG Ratio
0.024484154417798
Enterprise to EBITDA
-1.404
Enterprise to revenue
7284.042
Price to book MRQ
1.6769415
Price to sales TTM
12679.733
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-12-31
Revenue (TTM)
36000
EBITDA
-186746000
Diluted EPS TTM
-16.06
Total Cash (MRQ)
247.2M
Current ratio (MRQ)
5.281
Operating Cash Flow (TTM)
-150024000
LYEL trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
March 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
